FIELD: medicine.
SUBSTANCE: present invention refers to medicine, namely to physiology and space medicine, and concerns prevention of skeletal muscle atrophy at their functional unloading. To this end, an effective amount of compound VX 745 is introduced.
EFFECT: this compound, being a p38 MAPK phosphorylation inhibitor, reduces the expression level of MuRF-1 E3-ligase, ubiquitin and calpain-1 mRNA, which in turn provides effective prevention of skeletal muscle atrophy in hypokinesia or gravity unloading.
4 cl, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTING AND REDUCING DESTRUCTION OF SKELETAL PROTEINS OF ATROPHIED SKELETAL MUSCLES CAUSED BY HYPOKINESIA AND/OR DISCHARGE BY GRAVITY | 2013 |
|
RU2517259C1 |
METHOD FOR PREVENTING AND REDUCING DESTRUCTION OF SKELETAL PROTEINS OF ATROPHIED SKELETAL MUSCLES CAUSED BY HYPOKINESIA AND/OR DISCHARGE BY GRAVITY | 2013 |
|
RU2517576C1 |
METHOD OF PREVENTING ATROPHY OF SKELETAL MUSCLES DURING THEIR FUNCTIONAL UNLOADING | 2022 |
|
RU2797216C1 |
METHOD FOR PREVENTION OF SKELETAL MUSCLE ATROPHY AFTER FUNCTIONAL UNLOADING | 2012 |
|
RU2481105C1 |
METHOD FOR PREVENTING AND REDUCING DESTRUCTION OF CYTOSKELETAL PROTEINS OF ATROPHIED SKELETAL MUSCLES CAUSED BY HYPOKINESIA AND/OR DISCHARGE BY GRAVITY | 2010 |
|
RU2444354C2 |
METHOD TO PREVENT DEVELOPMENT OF SKELETAL MUSCLE FATIGUE | 2023 |
|
RU2814077C1 |
METHOD OF MAINTAINING THE STRENGTH AND RIGIDITY OF THE POSTURAL MUSCLES OF MAMMALS DURING THEIR FUNCTIONAL UNLOADING | 2022 |
|
RU2800317C1 |
INHIBITOR OF EXERTIONAL CYTOSKELETAL PROTEOLYSIS OF SKELETAL MUSCLES | 2008 |
|
RU2389486C1 |
METHOD OF PREVENTING CYTOSCELETAL PROTEINS DESTRUCTION IN SCELETAL MUSCLES WITHIN ECCENTRIC LOAD | 2008 |
|
RU2391968C1 |
METHOD TO ACCELERATE RECOVERY OF SKELETAL MUSCLES ATROPHY AFTER A LONG ALCOHOL INTOXICATION | 2014 |
|
RU2578463C1 |
Authors
Dates
2020-02-21—Published
2019-03-20—Filed